Composition for preventing, alleviating or treating metabolic syndrome accompanied by obesity and/or diabetes, containing, as active ingredient, complex (IB complex) of indian gooseberry extract and sprout barley extract

Abstract

The present invention relates to a composition for preventing, alleviating or treating metabolic syndrome, containing, as an active ingredient, a complex of an Indian gooseberry (amla) extract and a sprout barley extract. Particularly, a complex of Indian gooseberry extract and a sprout barley extract, according to the present invention, exhibits a synergistic effect in the alleviation of obesity or diabetes by reducing body weight, blood sugar, blood insulin, and blood glycated hemoglobin, and thus can be used as a pharmaceutical composition or a health functional food for preventing or treating metabolic syndrome such as obesity and diabetes.

Description

[0001] This application claims priority based on Korean Patent Application No. 10-2019-0064098 filed on May 30, 2019, and all the contents disclosed in the specification and drawings of the corresponding application are incorporated in this application. technical field [0002] The present invention relates to a composition for preventing, improving or treating metabolic syndrome comprising a natural extract as an active ingredient. Background technique [0003] Obesity refers to a condition in which fat accumulates excessively in the body, and it can be caused by various reasons such as genetic factors, lack of exercise, stress, hormonal imbalance, and Westernized diet, etc. Recently, the prevalence of obesity is increasing year by year due to the imbalance of energy intake and expenditure, and according to the 2017 National Health and Nutrition Survey (National Health and Nutrition Survey), the obesity rate in Korea over the age of 19 was 34.1%, and This is an increase of ...

AI Technical Summary

Problems solved by technology

Representative obesity therapeutic agents include appetite suppressants (such as phentermine, phenmetrazine, mazindol, etc.) and fat absorption inhibitors (such as orlistat), but appetite suppressants have a problem in that they stimulate The central nervo

Images